Skip to main content
Photo of  Henry A. Nasrallah, MD

Henry A. Nasrallah, MD

Professor-Emeritus

Psychiatry & Behavioral Neuroscience | College of Medicine

Education/Credentials
  • Medical Degree: American University of Beirut
  • Residency: University of Rochester
  • Fellowship: National Institutes of Health
Board Certifications & Licenses

American Board of Psychiatry and Neurology (Psychiatry) (Certification Date: 19770430)

Contact Information
Research Interests

Dr. Nasrallah's research focus is on the neurobiology and psychopharmacology of schizophrenia and related disorders.

Clinical Interests

Psychiatry

Bipolar Disorder

Mood Disorders

Major Depressive Disorder

Psychotic Disorders

Schizophrenia

Peer Reviewed Publications

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel; Rastgar, Yasha; Berry, James; Hill, Cheryl; Justice, John; Zheng, Wanhong; Pearson, Nathan; Gallucci, Gerard; Figgs, Patricia; Hustead, Jeremy; Vogt, Joel; Zafar, Jawad; Dohar, Sheena; Looper, Robert; Guinan, Danielle; Elawady, Akram; Shah, Omar; Lam, Mei Wai; Shagufta, Shanila; Schwartzman, Noah; Hamric, Eddie; Mayle, Lauren; Miller, Mark; Chandran, Dilip; Marshalek, Patrick; Moreland, Rachel; Tamang, Tenchee Lama; Mattancheril, Sunny; Berzingi, Sara 2021. Measurement-based care training curriculum in psychiatry residency programs: I: Description of the curriculum and demonstration of implementation. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 33 3, 168-179

Nasrallah, Henry A 2021. Re-inventing the DSM as a transdiagnostic model: Psychiatric disorders are extensively interconnected. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 33 3, 148-150

Nasrallah, Henry A 2021. The pro- and con-debate about the at-risk state and early intervention: A commentary. Schizophrenia research, 227 , 18-19

Nasrallah, Henry A; Weiden, Peter J; Walling, David P; Du, Yangchun; Yao, Baiyun; Yagoda, Sergey; Claxton, Amy 2021. Aripiprazole lauroxil 2-month formulation with 1-day initiation in patients hospitalized for an acute exacerbation of schizophrenia: exploratory efficacy and patient-reported outcomes in the randomized controlled ALPINE study. BMC psychiatry, 21 1, 492

Sagarwala, Raza; Nasrallah, Henry A 2021. The effect of antipsychotic medications on white matter integrity in first-episode drug-naïve patients with psychosis: A review of DTI studies. Asian journal of psychiatry, 61 , 102688

Sagarwala, Raza; Nasrallah, Henry A 2020. White matter pathology in patients with borderline personality disorder: A review of controlled DTI studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 4, 281-286

Sagarwala, Raza; Nasrallah, Henry A 2020. The effects of yoga on depression and motor function in patients with Parkinson's disease: A review of controlled studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 3, 209-215

Sagarwala, Raza; Nasrallah, Henry A 2020. A systematic review of diffusion tensor imaging studies in drug-naïve OCD patients before and after pharmacotherapy. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 32 1, 42-47

Cannon, Cornita; Nasrallah, Henry A 2019. A focus on postpartum depression among African American women: A literature review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 2, 138-143

Chen, Alexander T; Nasrallah, Henry A 2019. Neuroprotective effects of the second generation antipsychotics. Schizophrenia research, 208 , 1-7

Douglas, Jasmine; Nasrallah, Henry A 2019. Low high-density lipoprotein and psychopathology: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 3, 209-213

Kahlon, Chanchal K; Nasrallah, Henry A 2019. Bidirectional relationship between transient ischemic attacks and depression: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 3, 214-220

Nasrallah, Henry A; Aquila, Ralph; Du, Yangchun; Stanford, Arielle D; Claxton, Amy; Weiden, Peter J 2019. Long-term safety and tolerability of aripiprazole lauroxil in patients with schizophrenia. CNS spectrums, 24 4, 395-403

Nasrallah, Henry A; Fedora, Rissa; Morton, Robert 2019. Successful treatment of clozapine-nonresponsive refractory hallucinations and delusions with pimavanserin, a serotonin 5HT-2A receptor inverse agonist. Schizophrenia research, 208 , 217-220

Sagarwala, Raza; Nasrallah, Henry A 2019. Changes in inflammatory biomarkers before and after SSRI therapy in PTSD: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 31 4, 292-297

Aboraya, Ahmed; Nasrallah, Henry A; Elswick, Daniel E; Ahmed, Elshazly; Estephan, Nevine; Aboraya, Dalia; Berzingi, Seher; Chumbers, Josleen; Berzingi, Sara; Justice, John; Zafar, Jawad; Dohar, Sheena 2018. Measurement-based Care in Psychiatry-Past, Present, and Future. Innovations in clinical neuroscience, 15 11-12, 13-26

Adams, Selin A; Nasrallah, Henry A 2018. Multiple retinal anomalies in schizophrenia. Schizophrenia research, 195 , 3-12

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A 2018. Body temperature rises following improvement of depression with ECT. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 3, 196-199

Chen, Alexander T; Malmstrom, Theodore; Nasrallah, Henry A 2018. Allopurinol augmentation in acute mania: A meta-analysis of placebo-controlled trials. Journal of affective disorders, 226 , 245-250

Citrome, Leslie; Risinger, Robert; Cutler, Andrew J; Du, Yangchun; Zummo, Jacqueline; Nasrallah, Henry A; Silverman, Bernard L 2018. Effect of aripiprazole lauroxil in patients with acute schizophrenia as assessed by the Positive and Negative Syndrome Scale-supportive analyses from a Phase 3 study. CNS spectrums, 23 4, 284-290

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Wolfgang Fleischhacker, W; Nasrallah, Henry A 2018. Corrigendum to "Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial" [Schizophr. Res. 176 (2016) 264-271]. Schizophrenia research, 192 , 493

Khoury, Rita; Nasrallah, Henry A 2018. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait? Schizophrenia research, 199 , 31-38

Lu, Syshane; Nasrallah, Henry A 2018. The use of memantine in neuropsychiatric disorders: An overview. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 3, 234-248

Nasrallah, Henry A 2018. Triple advantages of injectable long acting second generation antipsychotics: Relapse prevention, neuroprotection, and lower mortality. Schizophrenia research, 197 , 69-70

Sagarwala, Raza; Malmstrom, Theodore; Nasrallah, Henry A 2018. Effects of nonpharmacological therapies on anxiety and cortisol: A meta-analysis. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 30 2, 91-96

Aboraya, Ahmed; Leucht, Stefan; Nasrallah, Henry A; Samara, Myrto; Haro, Josep Maria; Elshazly, Ahmed; Zangeneh, Masood 2017. A novel approach to measuring response and remission in schizophrenia in clinical trials. Schizophrenia research, 190 , 123-128

Blanchard, Jack J; Bradshaw, Kristen R; Garcia, Cristina P; Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric 2017. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study. Schizophrenia research, 185 , 137-143

Durgam, Suresh; Landbloom, Ronald P; Mackle, Mary; Wu, Xiao; Mathews, Maju; Nasrallah, Henry A 2017. Exploring the long-term safety of asenapine in adults with schizophrenia in a double-blind, fixed-dose, extension study. Neuropsychiatric disease and treatment, 13 , 2021-2035

Keshavan, Matcheri S; DeLisi, Lynn E; Nasrallah, Henry A 2017. Translational and spectrum aspects of Schizophrenia Research: The rationale for new journal's new subheading. Schizophrenia research, 179 , 1

Keshavan, Matcheri S; Lawler, Ashley N; Nasrallah, Henry A; Tandon, Rajiv 2017. New drug developments in psychosis: Challenges, opportunities and strategies. Progress in neurobiology, 152 , 3-20

Nasrallah, Henry A; Aquila, Ralph; Stanford, Arielle D; Jamal, Hasan H; Weiden, Peter J; Risinger, Robert 2017. Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil. Psychopharmacology bulletin, 47 3, 35-43

Nasrallah, Henry A; Chen, Alexander T 2017. Multiple neurotoxic effects of haloperidol resulting in neuronal death. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29 3, 195-202

Nasrallah, Henry A; Earley, Willie; Cutler, Andrew J; Wang, Yao; Lu, Kaifeng; Laszlovszky, István; Németh, György; Durgam, Suresh 2017. The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis. BMC psychiatry, 17 1, 305

Upadhyaya, Mihir A; Nasrallah, Henry A 2017. The intense desire for healthy limb amputation: A dis-proprioceptive neuropsychiatric disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 29 2, 125-132

Aboraya, Ahmed; Nasrallah, Henry A 2016. Perspectives on the Positive and Negative Syndrome Scale (PANSS): Use, misuse, drawbacks, and a new alternative for schizophrenia research. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 2, 125-31

Alphs, Larry; Nasrallah, Henry A; Bossie, Cynthia A; Fu, Dong-Jing; Gopal, Srihari; Hough, David; Turkoz, Ibrahim 2016. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy. International clinical psychopharmacology, 31 4, 202-9

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A 2016. Placebo-controlled augmentation trials of the antioxidant NAC in schizophrenia: A review. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 3, 190-6

Durgam, Suresh; Earley, Willie; Li, Rui; Li, Dayong; Lu, Kaifeng; Laszlovszky, István; Fleischhacker, W Wolfgang; Nasrallah, Henry A 2016. Long-term cariprazine treatment for the prevention of relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled trial. Schizophrenia research, 176 2-3, 264-271

Gondim, Francisco de Assis Aquino; Thomas, Florian P; Cruz-Flores, Salvador; Nasrallah, Henry A; Selhorst, John B 2016. Pathological laughter and crying: A case series and proposal for a new classification. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 28 1, 11-21

Nasrallah, Henry A 2016. A Valedictory from the Founding Editors. Schizophrenia research, 175 1-3, 1

Nasrallah, Henry A; Newcomer, John W; Risinger, Robert; Du, Yangchun; Zummo, Jacqueline; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W 2016. Effect of Aripiprazole Lauroxil on Metabolic and Endocrine Profiles and Related Safety Considerations Among Patients With Acute Schizophrenia. The Journal of clinical psychiatry, 77 11, 1519-1525

Yum, Sun Young; Hwang, Michael Y; Nasrallah, Henry A; Opler, Lewis A 2016. Transcending Psychosis: The Complexity of Comorbidity in Schizophrenia. The Psychiatric clinics of North America, 39 2, 267-74

Chen, Alexander T; Chibnall, John T; Nasrallah, Henry A 2015. A meta-analysis of placebo-controlled trials of omega-3 fatty acid augmentation in schizophrenia: Possible stage-specific effects. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 4, 289-96

Lawson, William; Johnston, Stephen; Karson, Craig; Offord, Steve; Docherty, John; Eramo, Anna; Kamat, Siddhesh; Blanchette, Christopher M; Carson, William; Nasrallah, Henry A 2015. Racial differences in antipsychotic use: Claims database analysis of Medicaid-insured patients with schizophrenia. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 4, 242-52

Meltzer, Herbert Y; Risinger, Robert; Nasrallah, Henry A; Du, Yangchun; Zummo, Jacqueline; Corey, Lisa; Bose, Anjana; Stankovic, Srdjan; Silverman, Bernard L; Ehrich, Elliot W 2015. A randomized, double-blind, placebo-controlled trial of aripiprazole lauroxil in acute exacerbation of schizophrenia. The Journal of clinical psychiatry, 76 8, 1085-90

Nasrallah, Henry A 2015. Toward the era of transformational neuropsychiatry. Asian journal of psychiatry, 17 , 140-1

Nasrallah, Henry A 2015. Consequences of misdiagnosis: inaccurate treatment and poor patient outcomes in bipolar disorder. The Journal of clinical psychiatry, 76 10, e1328

Nasrallah, Henry A; Cucchiaro, Josephine B; Mao, Yongcai; Pikalov, Andrei A; Loebel, Antony D 2015. Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies. CNS spectrums, 20 2, 140-7

Nasrallah, Henry A; Harvey, Philip D; Casey, Daniel; Csoboth, Csilla T; Hudson, James I; Julian, Laura; Lentz, Ellen; Nuechterlein, Keith H; Perkins, Diana O; Kotowsky, Nirali; Skale, Tracey G; Snowden, Lonnie R; Tandon, Rajiv; Tek, Cenk; Velligan, Dawn; Vinogradov, Sophia; O'Gorman, Cedric 2015. The Management of Schizophrenia in Clinical Practice (MOSAIC) Registry: a focus on patients, caregivers, illness severity, functional status, disease burden and healthcare utilization. Schizophrenia research, 166 1-3, 69-79

Schooler, Nina R; Buchanan, Robert W; Laughren, Thomas; Leucht, Stefan; Nasrallah, Henry A; Potkin, Steven G; Abi-Saab, Danielle; Berardo, Carmen Galani; Bugarski-Kirola, Dragana; Blaettler, Thomas; Edgar, Chris J; Nordstroem, Anna-Lena; O'Gorman, Cedric; Garibaldi, George 2015. Defining therapeutic benefit for people with schizophrenia: focus on negative symptoms. Schizophrenia research, 162 1-3, 169-74

Serafini, Gianluca; Gonda, Xenia; Rihmer, Zoltan; Pompili, Maurizio; Girardi, Paolo; Nasrallah, Henry A; Amore, Mario 2015. NMDA receptor antagonists for depression: Critical considerations. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 27 3, 213-20

Park, Sohee; Nasrallah, Henry A 2014. The varieties of anomalous self experiences in schizophrenia: splitting of the mind at a crossroad. Schizophrenia research, 152 1, 1-4

Keshavan, M S; Tandon, R; Nasrallah, H A 2013. Renaming schizophrenia: keeping up with the facts. Schizophrenia research, 148 1-3, 1-2

McEvoy, Joseph; Baillie, Rebecca A; Zhu, Hongjie; Buckley, Peter; Keshavan, Matcheri S; Nasrallah, Henry A; Dougherty, George G; Yao, Jeffrey K; Kaddurah-Daouk, Rima 2013. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PloS one, 8 7, e68717

Nasrallah, Henry A; Delisi, Lynn E 2013. 25 years of editing Schizophrenia research: a unique and gratifying journey. Schizophrenia research, 143 1, 1-2

Nasrallah, Henry A; Silva, Robert; Phillips, Debra; Cucchiaro, Josephine; Hsu, Jay; Xu, Jane; Loebel, Antony 2013. Lurasidone for the treatment of acutely psychotic patients with schizophrenia: a 6-week, randomized, placebo-controlled study. Journal of psychiatric research, 47 5, 670-7

Ravyn, Dana; Ravyn, Vipa; Lowney, Robert; Nasrallah, Henry A 2013. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence. Schizophrenia research, 149 1-3, 1-14

Stroup, T Scott; Byerly, Matthew J; Nasrallah, Henry A; Ray, Neepa; Khan, Ahsan Y; Lamberti, J Steven; Glick, Ira D; Steinbook, Richard M; McEvoy, Joseph P; Hamer, Robert M 2013. Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial. Schizophrenia research, 146 1-3, 190-5

Watson, A M M; Prasad, K M; Klei, L; Wood, J A; Yolken, R H; Gur, R C; Bradford, L D; Calkins, M E; Richard, J; Edwards, N; Savage, R M; Allen, T B; Kwentus, J; McEvoy, J P; Santos, A B; Wiener, H W; Go, R C P; Perry, R T; Nasrallah, H A; Gur, R E; Devlin, B; Nimgaonkar, V L 2013. Persistent infection with neurotropic herpes viruses and cognitive impairment. Psychological medicine, 43 5, 1023-31

Bamne, Mikhil; Wood, Joel; Chowdari, Kodavali; Watson, Annie M; Celik, Cemil; Mansour, Hader; Klei, Lambertus; Gur, Ruben C; Bradford, L DiAnne; Calkins, Monica E; Santos, Alberto B; Edwards, Neil; Kwentus, Joseph; McEvoy, Joseph P; Allen, Trina B; Savage, Robert M; Nasrallah, Henry A; Gur, Raquel E; Perry, Rodney T; Go, Rodney C P; Devlin, Bernie; Yolken, Robert; Nimgaonkar, Vishwajit L 2012. Evaluation of HLA polymorphisms in relation to schizophrenia risk and infectious exposure. Schizophrenia bulletin, 38 6, 1149-54

Citrome, Leslie; Nasrallah, Henry A 2012. On-label on the table: what the package insert informs us about the tolerability profile of oral atypical antipsychotics, and what it does not. Expert opinion on pharmacotherapy, 13 11, 1599-613

Gilday, Elizabeth; Nasrallah, Henry A 2012. Clinical pharmacology of paliperidone palmitate a parenteral long-acting formulation for the treatment of schizophrenia. Reviews on recent clinical trials, 7 1, 2-9

Gohlke, Julia M; Dhurandhar, Emily J; Correll, Christoph U; Morrato, Elaine H; Newcomer, John W; Remington, Gary; Nasrallah, Henry A; Crystal, Stephen; Nicol, Ginger ; Allison, David B 2012. Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs. Frontiers in psychiatry, 3 , 62

Hudepohl, Neha S; Nasrallah, Henry A 2012. Antipsychotic drugs. Handbook of clinical neurology, 106 , 657-67

Kaddurah-Daouk, Rima; McEvoy, Joseph; Baillie, Rebecca; Zhu, Hongjie; K Yao, Jeffrey; Nimgaonkar, Vishwajit L; Buckley, Peter F; Keshavan, Matcheri S; Georgiades, Anastasia; Nasrallah, Henry A 2012. Impaired plasmalogens in patients with schizophrenia. Psychiatry research, 198 3, 347-52

Nasrallah, Henry A 2012. Does the neurotoxicity of haloperidol explain the higher mortality in dementia patients compared with the second generation agents? The American journal of psychiatry, 169 6, 663-4; author reply

Jameson, Kathryn G; Nasrallah, Henry A; Northern, Tracie G; Welge, Jeffrey A 2011. Executive function impairment in first-degree relatives of persons with schizophrenia: A meta-analysis of controlled studies. Asian journal of psychiatry, 4 2, 96-9

Keshavan, Matcheri S; Nasrallah, Henry A; Tandon, Rajiv 2011. Schizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse. Schizophrenia research, 127 1-3, 3-13

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2011. "Just the facts": meandering in schizophrenia's many forests. Schizophrenia research, 128 1-3, 5-6

Devulapalli, Kavi; Nasrallah, Henry A 2010. Schizophrenia and obsessive-compulsive disorder. The American journal of psychiatry, 167 11, 1407-8

Nasrallah, Henry A 2010. Linkage of cognitive impairments with metabolic disorders in schizophrenia. The American journal of psychiatry, 167 10, 1155-7

Nasrallah, Henry A; Goldberg, Joseph F; Correll, Cristoph U 2010. Differential diagnosis and therapeutic management of schizoaffective disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 22 4 Suppl 1, S1-12

Nasrallah, Henry A; Gopal, Srihari; Gassmann-Mayer, Cristiana; Quiroz, Jorge A; Lim, Pilar; Eerdekens, Mariëlle; Yuen, Eric; Hough, David 2010. A controlled, evidence-based trial of paliperidone palmitate, a long-acting injectable antipsychotic, in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 35 10, 2072-82

Nasrallah, Henry A; Hopkins, Tracy; Pixley, Sarah K 2010. Differential effects of antipsychotic and antidepressant drugs on neurogenic regions in rats. Brain research, 1354 , 23-9

Shertzer, H G; Kendig, E L; Nasrallah, H A; Johansson, E; Genter, M B 2010. Protection from olanzapine-induced metabolic toxicity in mice by acetaminophen and tetrahydroindenoindole. International journal of obesity (2005), 34 6, 970-9

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2010. Schizophrenia, "just the facts" 5. Treatment and prevention. Past, present, and future. Schizophrenia research, 122 1-3, 1-23

Danielyan, Arman; Nasrallah, Henry A 2009. Neurological disorders in schizophrenia. The Psychiatric clinics of North America, 32 4, 719-57

Devulapalli, Kavi K; Nasrallah, Henry A 2009. An analysis of the high psychotropic off-label use in psychiatric disorders The majority of psychiatric diagnoses have no approved drug. Asian journal of psychiatry, 2 1, 29-36

Hwang, Michael Y; Nasrallah, Henry A 2009. Psychiatric and physical comorbidity in schizophrenia. Preface. The Psychiatric clinics of North America, 32 4, xiii-xv

Meyer, Jonathan M; McEvoy, Joseph P; Davis, Vicki G; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Hsiao, John K; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2009. Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study. Biological psychiatry, 66 11, 1013-22

Nasrallah, Henry A 2009. Meta-analysis trends in schizophrenia over three decades. Schizophrenia research, 108 1-3, 1-2

Nasrallah, Henry A; Keshavan, Matcheri S; Benes, Francine M; Braff, David L; Green, Alan I; Gur, Raquel E; Kane, John M; Perkins, Diana O; Weiden, Peter J; Weinberger, Daniel R; Correll, Christoph U 2009. Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia. The Journal of clinical psychiatry, 70 Suppl 1 , 4-46

Tandon, Rajiv; Nasrallah, Henry A; Keshavan, Matcheri S 2009. Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia research, 110 1-3, 1-23

Wiener, H W; Klei, L; Irvin, M D; Perry, R T; Aliyu, M H; Allen, T B; Bradford, L D; Calkins, M E; Devlin, B; Edwards, N; Gur, R E; Gur, R C; Kwentus, J; Lyons, P D; McEvoy, J P; Nasrallah, H A; Nimgaonkar, V L; O'Jile, J; Santos, A B; Savage, R M; Go, R C P 2009. Linkage analysis of schizophrenia in African-American families. Schizophrenia research, 109 1-3, 70-9

Ali-Shtayeh, Mohammed S; Jamous, Rana M; Al-Shafie', Jehan H; Elgharabah, Wafa' A; Kherfan, Fatemah A; Qarariah, Kifayeh H; Khdair, Isra' S; Soos, Israa M; Musleh, Aseel A; Isa, Buthainah A; Herzallah, Hanan M; Khlaif, Rasha B; Aiash, Samiah M; Swaiti, Ghadah M; Abuzahra, Muna A; Haj-Ali, Maha M; Saifi, Nehaya A; Azem, Hebah K; Nasrallah, Hanadi A 2008. Traditional knowledge of wild edible plants used in Palestine (Northern West Bank): a comparative study. Journal of ethnobiology and ethnomedicine, 4 , 13

Daumit, Gail L; Goff, Donald C; Meyer, Jonathan M; Davis, Vicki G; Nasrallah, Henry A; McEvoy, Joseph P; Rosenheck, Robert; Davis, Sonia M; Hsiao, John K; Stroup, T Scott; Lieberman, Jeffrey A 2008. Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophrenia research, 105 1-3, 175-87

DeLisi, Lynn E; Nasrallah, Henry A 2008. Celebrating twenty years of schizophrenia research. Schizophrenia research, 100 1-3, 1-3

Devulapalli, Kavi K; Welge, Jeffrey A; Nasrallah, Henry A 2008. Temporal sequence of clinical manifestation in schizophrenia with co-morbid OCD: review and meta-analysis. Psychiatry research, 161 1, 105-8

Keshavan, Matcheri S; Tandon, Rajiv; Boutros, Nash N; Nasrallah, Henry A 2008. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology. Schizophrenia research, 106 2-3, 89-107

Meyer, Jonathan M; Davis, Vicki G; Goff, Donald C; McEvoy, Joseph P; Nasrallah, Henry A; Davis, Sonia M; Rosenheck, Robert A; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2008. Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1. Schizophrenia research, 101 1-3, 273-86

Meyer, Jonathan M; Davis, Vicki G; McEvoy, Joseph P; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Daumit, Gail L; Hsiao, John; Swartz, Marvin S; Stroup, T Scott; Lieberman, Jeffrey A 2008. Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1. Schizophrenia research, 103 1-3, 104-9

Nasrallah, H A 2008. Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles. Molecular psychiatry, 13 1, 27-35

Nasrallah, Henry A 2008. The urgent need for monitoring and intervention to reduce metabolic risk factors in patients with schizophrenia. CNS spectrums, 13 6 Suppl 10, 5-6

Nasrallah, Henry A; Black, Donald W; Goldberg, Joseph F; Muzina, David J; Pariser, Stephen F 2008. Diagnosing and managing psychotic and mood disorders. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 20 Suppl 1 , S1-28; quiz S29-30

Newcomer, John W; Nasrallah, Henry A; McIntyre, Roger S; McIntyre, Roger S; Vogel-Scibilia, Suzanne 2008. Elevating the standard of care in the management of cardiometabolic risk factors in patients with mental illness. Conclusion: summary and recommendations. CNS spectrums, 13 6 Suppl 10, 13-4

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A 2008. Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology. Schizophrenia research, 102 1-3, 1-18

Tandon, Rajiv; Keshavan, Matcheri S; Nasrallah, Henry A 2008. Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview. Schizophrenia research, 100 1-3, 4-19

Cerullo, Michael A; Adler, Caleb M; Strakowski, Stephen M; Eliassen, James C; Nasrallah, Henry A; Nasrallah, Amelia T 2007. Memantine normalizes brain activity in the inferior frontal gyrus: a controlled pilot fMRI study. Schizophrenia research, 97 1-3, 294-6

Dlugosz, Heather; Nasrallah, Henry A 2007. Paliperidone: a new extended-release oral atypical antipsychotic. Expert opinion on pharmacotherapy, 8 14, 2307-13

Nasrallah, H A 2007. The case for long-acting antipsychotic agents in the post-CATIE era. Acta psychiatrica Scandinavica, 115 4, 260-7

Nasrallah, Henry A 2007. The roles of efficacy, safety, and tolerability in antipsychotic effectiveness: practical implications of the CATIE schizophrenia trial. The Journal of clinical psychiatry, 68 Suppl 1 , 5-11

Nasrallah, Henry A 2007. Introduction: evaluating the evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and beyond. The Journal of clinical psychiatry, 68 Suppl 1 , 3-4

Ketter, Terence A; Nasrallah, Henry A; Fagiolini, Andrea 2006. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder. Psychopharmacology bulletin, 39 1, 120-46

Nasrallah, Henry A 2006. Metabolic findings from the CATIE trial and their relation to tolerability. CNS spectrums, 11 7 Suppl 7, 32-9

Nasrallah, Henry A; Brecher, Martin; Paulsson, Björn 2006. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar disorders, 8 5 Pt 1, 467-74

Nasrallah, Henry A; Dursun, Serdar M 2006. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy. Journal of psychopharmacology (Oxford, England), 20 6 Suppl, 3-5

Nasrallah, Henry A; Ketter, Terence A; Kalali, Amir H 2006. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature. Journal of affective disorders, 95 1-3, 69-78

Nasrallah, Henry A; Lasser, Rob 2006. Improving patient outcomes in schizophrenia: achieving remission. Journal of psychopharmacology (Oxford, England), 20 6 Suppl, 57-61

Nasrallah, Henry A; Meyer, Jonathan M; Goff, Donald C; McEvoy, Joseph P; Davis, Sonia M; Stroup, T Scott; Lieberman, Jeffrey A 2006. Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophrenia research, 86 1-3, 15-22

Singh, Manpreet K; Giles, Lisa L; Nasrallah, Henry A 2006. Pain insensitivity in schizophrenia: trait or state marker? Journal of psychiatric practice, 12 2, 90-102

Tandon, Rajiv; Nasrallah, Henry A 2006. Subjecting meta-analyses to closer scrutiny: Little support for differential efficacy among second-generation antipsychotics at equivalent doses. Archives of general psychiatry, 63 8, 935-7; author reply

Tandon, Rajiv; Targum, Steven D; Nasrallah, Henry A; Ross, Ruth 2006. Strategies for maximizing clinical effectiveness in the treatment of schizophrenia. Journal of psychiatric practice, 12 6, 348-63

Terry, Alvin V; Parikh, Vinay; Gearhart, Debra A; Pillai, Anilkumar; Hohnadel, Elizabeth; Warner, Samantha; Nasrallah, Henry A; Mahadik, Sahebarao P 2006. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. The Journal of pharmacology and experimental therapeutics, 318 2, 709-24

Delisi, L E; Nasrallah, H A 2005. The CATIE schizophrenia effectiveness trial. Schizophrenia research, 80 1, v-vi

Goff, Donald C; Sullivan, Lisa M; McEvoy, Joseph P; Meyer, Jonathan M; Nasrallah, Henry A; Daumit, Gail L; Lamberti, Steven; D'Agostino, Ralph B; Stroup, Thomas S; Davis, Sonia; Lieberman, Jeffrey A 2005. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophrenia research, 80 1, 45-53

McEvoy, Joseph P; Meyer, Jonathan M; Goff, Donald C; Nasrallah, Henry A; Davis, Sonia M; Sullivan, Lisa; Meltzer, Herbert Y; Hsiao, John; Scott Stroup, T; Lieberman, Jeffrey A 2005. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophrenia research, 80 1, 19-32

Meyer, Jonathan M; Nasrallah, Henry A; McEvoy, Joseph P; Goff, Donald C; Davis, Sonia M; Chakos, Miranda; Patel, Jayendra K; Keefe, Richard S E; Stroup, T Scott; Lieberman, Jeffrey A 2005. The Clinical Antipsychotic Trials Of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophrenia research, 80 1, 9-18

Nasrallah, Henry A 2005. Neurologic comorbidities in schizophrenia. The Journal of clinical psychiatry, 66 Suppl 6 , 34-46

Nasrallah, Henry A 2005. An overview of common medical comorbidities in patients with schizophrenia. The Journal of clinical psychiatry, 66 Suppl 6 , 3-4

Nasrallah, Henry A; Targum, Steven D; Tandon, Rajiv; McCombs, Jeffrey S; Ross, Ruth 2005. Defining and measuring clinical effectiveness in the treatment of schizophrenia. Psychiatric services (Washington, D.C.), 56 3, 273-82

Keith, Samuel J; Kane, John M; Turner, Martin; Conley, Robert R; Nasrallah, Henry A 2004. Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics. The Journal of clinical psychiatry, 65 1, 120-31

Lasser, Robert; Bossie, Cynthia A; Gharabawi, Georges; Eerdekens, Marielle; Nasrallah, Henry A 2004. Efficacy and safety of long-acting risperidone in stable patients with schizoaffective disorder. Journal of affective disorders, 83 2-3, 263-75

Menon, P Mohanakrishnan; Nasrallah, Henry A; Reeves, Roy R; Ali, Jeffrey A 2004. Hippocampal dysfunction in Gulf War Syndrome. A proton MR spectroscopy study. Brain research, 1009 1-2, 189-94

Mittal, Dinesh; Jimerson, Nita A; Neely, Emily P; Johnson, William D; Kennedy, Richard E; Torres, Rafael A; Nasrallah, Henry A 2004. Risperidone in the treatment of delirium: results from a prospective open-label trial. The Journal of clinical psychiatry, 65 5, 662-7

Nasrallah, Henry A; Duchesne, Inge; Mehnert, Angelika; Janagap, Carmela; Eerdekens, Mariëlle 2004. Health-related quality of life in patients with schizophrenia during treatment with long-acting, injectable risperidone. The Journal of clinical psychiatry, 65 4, 531-6

Nasrallah, Henry A; Newcomer, John W 2004. Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care. Journal of clinical psychopharmacology, 24 5 Suppl 1, S7-14

Newcomer, John W; Nasrallah, Henry A; Loebel, Antony D 2004. The Atypical Antipsychotic Therapy and Metabolic Issues National Survey: practice patterns and knowledge of psychiatrists. Journal of clinical psychopharmacology, 24 5 Suppl 1, S1-6

Gianfrancesco, Frank; White, Richard; Wang, Ruey-hua; Nasrallah, Henry A 2003. Antipsychotic-induced type 2 diabetes: evidence from a large health plan database. Journal of clinical psychopharmacology, 23 4, 328-35

Mohanakrishnan Menon, P; Nasrallah, Henry A; Lyons, Judith A; Scott, Mertis F; Liberto, Vincent 2003. Single-voxel proton MR spectroscopy of right versus left hippocampi in PTSD. Psychiatry research, 123 2, 101-8

Möller, Hans-Jürgen; Nasrallah, Henry A 2003. Treatment of bipolar disorder. The Journal of clinical psychiatry, 64 Suppl 6 , 9-17; discussion 28

Nasrallah, Hassan A; Balling, Robert C; Madi, Shaker Mohammed; Al-Ansari, Lamya 2003. Temporal variations in atmospheric CO2 concentrations in Kuwait City, Kuwait with comparisons to Phoenix, Arizona, USA. Environmental pollution (Barking, Essex : 1987), 121 2, 301-5

Nasrallah, Henry A 2003. Factors in antipsychotic drug selection: tolerability considerations. CNS spectrums, 8 11 Suppl 2, 23-5

Gianfrancesco, Frank D; Grogg, Amy L; Mahmoud, Ramy A; Wang, Ruey-hua; Nasrallah, Henry A 2002. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. The Journal of clinical psychiatry, 63 10, 920-30

Nasrallah, Henry A 2002. Pharmacoeconomic implications of adverse effects during antipsychotic drug therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 59 22 Suppl 8, S16-21

Nasrallah, Henry A; Tandon, Rajiv 2002. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia. The Journal of clinical psychiatry, 63 Suppl 13 , 12-20

Nasrallah, H A; Mulvihill, T 2001. Iatrogenic disorders associated with conventional vs. atypical antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 13 4, 215-27

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A 1998. Neuropsychological correlates of negative, disorganized and psychotic symptoms in schizophrenia. Schizophrenia research, 31 2-3, 99-111

Niedermier, J A; Nasrallah, H A 1998. Clinical correlates of response to valproate in geriatric inpatients. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 10 4, 165-8

Basso, M R; Nasrallah, H A; Olson, S C; Bornstein, R A 1997. Cognitive deficits distinguish patients with adolescent- and adult-onset schizophrenia. Neuropsychiatry, neuropsychology, and behavioral neurology, 10 2, 107-12

Nasrallah, H A; Sharma, S; Olson, S C 1997. The volume of the entorhinal cortex in schizophrenia: a controlled MRI study. Progress in neuro-psychopharmacology & biological psychiatry, 21 8, 1317-22

Nasrallah, H A; Tolbert, H A 1997. Neurobiology and neuroplasticity in schizophrenia. Continuity across the life cycle. Archives of general psychiatry, 54 10, 913-4

Pariser, S F; Nasrallah, H A; Gardner, D K 1997. Postpartum mood disorders: clinical perspectives. Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research, 6 4, 421-34

Boutros, N N; Torello, M W; Barker, B A; Tueting, P A; Wu, S C; Nasrallah, H A 1995. The P50 evoked potential component and mismatch detection in normal volunteers: implications for the study of sensory gating. Psychiatry research, 57 1, 83-8

Boutros, N; Torello, M W; Burns, E M; Wu, S S; Nasrallah, H A 1995. Evoked potentials in subjects at risk for Alzheimer's disease. Psychiatry research, 57 1, 57-63

Nasrallah, H A 1995. Brain and CSF volume differences in schizophrenic subtypes. The American journal of psychiatry, 152 5, 817; author reply 81

Nasrallah, H A; Balling, R C 1995. Impact of desertification on temperature trends in the Middle East. Environmental monitoring and assessment, 37 1-3, 265-71

Beason-Hazen, S; Nasrallah, H A; Bornstein, R A 1994. Self-report of symptoms and neuropsychological performance in asymptomatic HIV-positive individuals. The Journal of neuropsychiatry and clinical neurosciences, 6 1, 43-9

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1994. Duration of illness and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 6 2, 160-4

Nasrallah, H A; Skinner, T E; Schmalbrock, P; Robitaille, P M 1994. Proton magnetic resonance spectroscopy (1H MRS) of the hippocampal formation in schizophrenia: a pilot study. The British journal of psychiatry : the journal of mental science, 165 4, 481-5

Podraza, A M; Bornstein, R A; Whitacre, C C; Para, M F; Fass, R J; Rice, R R; Nasrallah, H A 1994. Neuropsychological performance and CD4 levels in HIV-1 asymptomatic infection. Journal of clinical and experimental neuropsychology, 16 5, 777-83

Bornstein, R A; Fama, R; Rosenberger, P; Whitacre, C C; Para, M F; Nasrallah, H A; Fass, R J 1993. Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 5 3, 254-9

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1993. Change in neuropsychological performance in asymptomatic HIV infection: 1-year follow-up. AIDS (London, England), 7 12, 1607-11

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J 1993. Neuropsychological performance in symptomatic and asymptomatic HIV infection. AIDS (London, England), 7 4, 519-24

Bornstein, R A; Pace, P; Rosenberger, P; Nasrallah, H A; Para, M F; Whitacre, C C; Fass, R J 1993. Depression and neuropsychological performance in asymptomatic HIV infection. The American journal of psychiatry, 150 6, 922-7

Jurjus, G J; Nasrallah, H A; Brogan, M; Olson, S C 1993. Developmental brain anomalies in schizophrenia and bipolar disorder: a controlled MRI study. The Journal of neuropsychiatry and clinical neurosciences, 5 4, 375-8

Jurjus, G J; Nasrallah, H A; Olson, S C; Schwarzkopf, S B 1993. Cavum septum pellucidum in schizophrenia, affective disorder and healthy controls: a magnetic resonance imaging study. Psychological medicine, 23 2, 319-22

McCoy, L; Votolato, N A; Schwarzkopf, S B; Nasrallah, H A 1993. Clinical correlates of valproate augmentation in refractory bipolar disorder. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 5 1, 29-33

Nasrallah, H A 1993. Neurodevelopmental pathogenesis of schizophrenia. The Psychiatric clinics of North America, 16 2, 269-80

Olson, S C; Bornstein, R A; Schwarzkopf, S B; Nasrallah, H A 1993. Are controls in schizophrenia research "normal"? Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 5 1, 1-5

Bornstein, R A; Chakeres, D; Brogan, M; Nasrallah, H A; Fass, R J; Para, M; Whitacre, C 1992. Magnetic resonance imaging of white matter lesions in HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 4 2, 174-8

Bornstein, R A; Nasrallah, H A; Para, M F; Whitacre, C C; Rosenberger, P; Fass, R J; Rice, R 1992. Neuropsychological performance in asymptomatic HIV infection. The Journal of neuropsychiatry and clinical neurosciences, 4 4, 386-94

Bornstein, R A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A 1992. Third-ventricle enlargement and neuropsychological deficit in schizophrenia. Biological psychiatry, 31 9, 954-61

Bornstein, R A; Nasrallah, H A; Para, M F; Fass, R J; Whitacre, C C; Rice, R R 1991. Rate of CD4 decline and neuropsychological performance in HIV infection. Archives of neurology, 48 7, 704-7

Nasrallah, H A 1991. Progressive and static ventriculomegaly in schizophrenia: clinical and methodological variables. Schizophrenia research, 5 3, 191-2

Nasrallah, H A 1991. Neurodevelopmental aspects of bipolar affective disorder. Biological psychiatry, 29 1, 1-2

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A 1991. Perinatal brain injury and cerebellar vermal lobules I-X in schizophrenia. Biological psychiatry, 29 6, 567-74

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Bogerts, B; McLaughlin, J A; Mitra, T 1991. Family history and brain morphology in schizophrenia: an MRI study. Psychiatry research, 40 1, 49-60

Bornstein, R A; Nasrallah, H A; Olson, S C; Coffman, J A; Torello, M; Schwarzkopf, S B 1990. Neuropsychological deficit in schizophrenic subtypes: paranoid, nonparanoid, and schizoaffective subgroups. Psychiatry research, 31 1, 15-24

Coffman, J A; Bornstein, R A; Olson, S C; Schwarzkopf, S B; Nasrallah, H A 1990. Cognitive impairment and cerebral structure by MRI in bipolar disorder. Biological psychiatry, 27 11, 1188-96

Coffman, J A; Torello, M W; Bornstein, R A; Chakeres, D; Burns, E; Nasrallah, H A 1990. Leukoaraiosis in asymptomatic adult offspring of individuals with Alzheimer's disease. Biological psychiatry, 27 11, 1244-8

Nasrallah, H A; Schwarzkopf, S B; Olson, S C; Coffman, J A 1990. Gender differences in schizophrenia on MRI brain scans. Schizophrenia bulletin, 16 2, 205-10

Paulman, R G; Devous, M D; Gregory, R R; Herman, J H; Jennings, L; Bonte, F J; Nasrallah, H A; Raese, J D 1990. Hypofrontality and cognitive impairment in schizophrenia: dynamic single-photon tomography and neuropsychological assessment of schizophrenic brain function. Biological psychiatry, 27 4, 377-99

Schwarzkopf, S B; Lamberti, J S; Jiminez, M; Kane, C F; Henricks, M; Nasrallah, H A 1990. Visual evoked potential correlates of positive/negative symptoms in schizophrenia. Biological psychiatry, 27 4, 400-10

Schwarzkopf, S B; Olson, S C; Coffman, J A; Nasrallah, H A 1990. Third and lateral ventricular volumes in schizophrenia: support for progressive enlargement of both structures. Psychopharmacology bulletin, 26 3, 385-91

Nasrallah, H A 1989. Right-hemisphere speech, callosal size, perinatal brain insult, and schizophrenia. Annals of neurology, 26 2, 290-1

Nasrallah, H A; Coffman, J A; Olson, S C 1989. Structural brain-imaging findings in affective disorders: an overview. The Journal of neuropsychiatry and clinical neurosciences, 1 1, 21-6

Schwarzkopf, S B; Nasrallah, H A; Olson, S C; Coffman, J A; McLaughlin, J A 1989. Perinatal complications and genetic loading in schizophrenia: preliminary findings. Psychiatry research, 27 3, 233-9

Nasrallah, H A; Churchill, C M; Hamdan-Allan, G A 1988. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. The American journal of psychiatry, 145 11, 1455-6

Schwarzkopf, S B; Chapman, R M; Jimenez, M; Treglia, L; Kane, C F; Lamberti, J S; Nasrallah, H A 1988. Familial and sporadic schizophrenia: visual evoked potential differences. Biological psychiatry, 24 7, 828-33

Burns, E M; Nasrallah, H A; Kathol, M H; Kruckeberg, T W; Coffman, J A 1987. Right vs. left hemispheric blood-brain barrier permeability in schizophrenia: a dynamic computed tomographic study. Psychiatry research, 22 3, 229-41

Coffman, J A; Nasrallah, H A; Lyskowski, J; McCalley-Whitters, M; Dunner, F J 1987. Clinical effectiveness of oral and parenteral rapid neuroleptization. The Journal of clinical psychiatry, 48 1, 20-4

Coffman, J A; Nasrallah, H A; Olson, S C 1987. Differences between schizophrenics and controls in CT-measured radiodensity of samples from the anterior corpus callosum. Acta psychiatrica Scandinavica, 75 4, 446

Wilcox, J A; Nasrallah, H A 1987. Childhood head trauma and psychosis. Psychiatry research, 21 4, 303-6

Wilcox, J A; Nasrallah, H A 1987. Perinatal distress and prognosis of psychotic illness. Neuropsychobiology, 17 4, 173-5

Wilcox, J A; Nasrallah, H A 1987. Perinatal insult as a risk factor in paranoid and nonparanoid schizophrenia. Psychopathology, 20 5-6, 285-7

Andreasen, N; Nasrallah, H A; Dunn, V; Olson, S C; Grove, W M; Ehrhardt, J C; Coffman, J A; Crossett, J H 1986. Structural abnormalities in the frontal system in schizophrenia. A magnetic resonance imaging study. Archives of general psychiatry, 43 2, 136-44

D'Mello, D A; Nasrallah, H A 1986. Suppression of tardive dyskinesia with amoxapine: case report. The Journal of clinical psychiatry, 47 3, 148

Lewis, D A; Nasrallah, H A 1986. Mania associated with electroconvulsive therapy. The Journal of clinical psychiatry, 47 7, 366-7

Nasrallah, H A; Andreasen, N C; Coffman, J A; Olson, S C; Dunn, V D; Ehrhardt, J C; Chapman, S M 1986. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biological psychiatry, 21 3, 274-82

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M; Smith, R E 1986. Pharmacologic probes of neurotransmitter systems in tardive dyskinesia: implications for clinical management. The Journal of clinical psychiatry, 47 2, 56-9

Nasrallah, H A; Loney, J; Olson, S C; McCalley-Whitters, M; Kramer, J; Jacoby, C G 1986. Cortical atrophy in young adults with a history of hyperactivity in childhood. Psychiatry research, 17 3, 241-6

Nasrallah, H A; Olson, S C; McCalley-Whitters, M; Chapman, S; Jacoby, C G 1986. Cerebral ventricular enlargement in schizophrenia. A preliminary follow-up study. Archives of general psychiatry, 43 2, 157-9

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S 1986. Opiate antagonism fails to reverse post-ECT cognitive deficits. The Journal of clinical psychiatry, 47 11, 555-6

Wilcox, J A; Nasrallah, H A 1986. Organic factors in catatonia. The British journal of psychiatry : the journal of mental science, 149 , 782-4

Wilcox, J A; Nasrallah, H A 1986. Sydenham's chorea and psychosis. Neuropsychobiology, 15 1, 13-4

Coffman, J A; Nasrallah, H A 1985. Relationships between brain density, cortical atrophy and ventriculomegaly in schizophrenia and mania. Acta psychiatrica Scandinavica, 72 2, 126-32

Coffman, J A; Olshansky, B; Nasrallah, H A; Skorton, D; Chapman, S 1985. Echocardiographic assessment of schizophrenics and manics: a reexamination of early necropsy findings. The Journal of nervous and mental disease, 173 3, 179-81

Jaeckle, R S; Nasrallah, H A 1985. Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa. The Journal of nervous and mental disease, 173 8, 503-8

Kronfol, Z; Nasrallah, H A; Chapman, S; House, J D 1985. Depression, cortisol metabolism and lymphocytopenia. Journal of affective disorders, 9 2, 169-73

Nasrallah, H A; Dunner, F J; McCalley-Whitters, M 1985. A placebo-controlled trial of valproate in tardive dyskinesia. Biological psychiatry, 20 2, 205-8

Nasrallah, H A; Jacoby, C G; Chapman, S; McCalley-Whitters, M 1985. Third ventricular enlargement on CT scans in schizophrenia: association with cerebellar atrophy. Biological psychiatry, 20 4, 443-50

Nasrallah, H A; Varney, N; Coffman, J A; Bayless, J; Chapman, S 1985. Effects of naloxone on cognitive deficits following electroconvulsive therapy. Psychopharmacology bulletin, 21 1, 89-90

Rogers, K L; Nasrallah, H A 1985. ECT was found to be effective in remitting the symptoms of late onset diabetes mellitus. Acta psychiatrica Scandinavica, 72 4, 402

Coffman, J A; Andreasen, N C; Nasrallah, H A 1984. Left hemispheric density deficits in chronic schizophrenia. Biological psychiatry, 19 8, 1237-47

Coffman, J A; Nasrallah, H A 1984. Statistical "noise" in CAT scan measurements. The American journal of psychiatry, 141 10, 1311-2

Coffman, J A; Nasrallah, H A 1984. Brain density patterns in schizophrenia and mania. Journal of affective disorders, 6 3-4, 307-15

Nasrallah, H A; Dunner, F J; Smith, R E; McCalley-Whitters, M; Sherman, A D 1984. Variable clinical response to choline in tardive dyskinesia. Psychological medicine, 14 3, 697-700

Nasrallah, H A; McCalley-Whitters, M 1984. Seasonality of birth in subtypes of chronic schizophrenia. Acta psychiatrica Scandinavica, 69 4, 292-5

Nasrallah, H A; McCalley-Whitters, M; Chapman, S 1984. Cerebral ventricular enlargement and suicide in schizophrenia and mania. The American journal of psychiatry, 141 7, 919

Nasrallah, H A; McCalley-Whitters, M; Pfohl, B 1984. Clinical significance of large cerebral ventricles in manic males. Psychiatry research, 13 2, 151-6

Tsai, L Y; Nasrallah, H A; Jacoby, C G 1984. Cerebral asymmetry in subtypes of schizophrenia. The Journal of clinical psychiatry, 45 10, 423-5

Wilson, R L; Waziri, R; Nasrallah, H A; McCalley-Whitters, M 1984. The lateralization of tardive dyskinesia. Biological psychiatry, 19 4, 629-35

Alexander, B; Nasrallah, H A; Perry, P J; Liskow, B I; Dunner, F J 1983. The impact of psychopharmacology education on prescribing practices. Hospital & community psychiatry, 34 12, 1150-3

Bigelow, L B; Nasrallah, H A; Rauscher, F P 1983. Corpus callosum thickness in chronic schizophrenia. The British journal of psychiatry : the journal of mental science, 142 , 284-7

Hamra, B J; Nasrallah, H A; Clancy, J; Finn, R 1983. Psychiatric diagnosis and risk for tardive dyskinesia. Archives of general psychiatry, 40 3, 346-7

McCalley-Whitters, M; Nasrallah, H A 1983. Tardive dyskinesia in a phantom limb. The British journal of psychiatry : the journal of mental science, 142 , 206-7

Nasrallah, H A; Keelor, K; McCalley-Whitters, M 1983. Laterality shift in alcoholic males. Biological psychiatry, 18 9, 1065-7

Nasrallah, H A; Kuperman, S; Hamra, B J; McCalley-Whitters, M 1983. Clinical differences between schizophrenic patients with and without large cerebral ventricles. The Journal of clinical psychiatry, 44 11, 407-9

Nasrallah, H A; Kuperman, S; Jacoby, C G; McCalley-Whitters, M; Hamra, B 1983. Clinical correlates of sulcal widening in chronic schizophrenia. Psychiatry research, 10 4, 237-42

Nasrallah, H A; McCalley-Whitters, M; Bigelow, L B; Rauscher, F P 1983. A histological study of the corpus callosum in chronic schizophrenia. Psychiatry research, 8 4, 251-60

Nasrallah, H A; Tippin, J; McCalley-Whitters, M 1983. Neurological soft signs in manic patients. A comparison with Schizophrenic and control groups. Journal of affective disorders, 5 1, 45-50

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H 1983. Sustained improvement in tardive dyskinesia with diazepam: indirect evidence for corticolimbic involvement. Brain research bulletin, 11 2, 179-85

Tsai, L Y; Nasrallah, H A; Jacoby, C G 1983. Hemispheric asymmetries on computed tomographic scans in schizophrenia and mania. A controlled study and a critical review. Archives of general psychiatry, 40 12, 1286-9

Lyskowski, J; Nasrallah, H A; Dunner, F J; Bucher, K 1982. A longitudinal survey of side effects in a lithium clinic. The Journal of clinical psychiatry, 43 7, 284-6

Nasrallah, H A 1982. Neuropathology of the corpus callosum in schizophrenia. The British journal of psychiatry : the journal of mental science, 141 , 99-100

Nasrallah, H A 1982. Hemispheric asymmetry in affective disorders. Psychopharmacology bulletin, 18 2, 62-7

Nasrallah, H A; Coryell, W H 1982. Dexamethasone nonsuppression predicts the antidepressant effects of sleep deprivation. Psychiatry research, 6 1, 61-64

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M; Kuperman, S 1982. Cerebral ventricular enlargement in subtypes of chronic schizophrenia. Archives of general psychiatry, 39 7, 774-7

Nasrallah, H A; Lyskowksi, J; Schroeder, D 1982. TCA-induced mania: differences between switchers and nonswitchers. Biological psychiatry, 17 2, 271-4

Nasrallah, H A; McCalley-Whitters, M 1982. Motor lateralization in manic males. The British journal of psychiatry : the journal of mental science, 140 , 521-2

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G 1982. Cortical atrophy in schizophrenia and mania: a comparative CT study. The Journal of clinical psychiatry, 43 11, 439-41

Nasrallah, H A; McCalley-Whitters, M; Jacoby, C G 1982. Cerebral ventricular enlargement in young manic males. A controlled CT study. Journal of affective disorders, 4 1, 15-9

Nasrallah, H A; McCalley-Whitters, M; Kuperman, S 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part I. sensory-motor lateralization. The Journal of clinical psychiatry, 43 8, 305-6

Nasrallah, H A; Rizzo, M; Damasio, H; McCalley-Whitters, M; Kuperman, S; Jacoby, C G 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part II. computerized tomographic findings. The Journal of clinical psychiatry, 43 8, 307-9

Nasrallah, H A; Schroeder, D; Petty, F 1982. Alcoholism secondary to essential tremor. The Journal of clinical psychiatry, 43 4, 163-4

Nasrallah, H A; Smith, R E; Dunner, F J; McCalley-Whitters, M 1982. Serotonin precursor effects in tardive dyskinesia. Psychopharmacology, 77 3, 234-5

Nasrallah, H A; Tippin, J; McCalley-Whitters, M; Kuperman, S 1982. Neurological differences between paranoid and nonparanoid schizophrenia: part III. neurological soft signs. The Journal of clinical psychiatry, 43 8, 310-2

Schroeder, D; Nasrallah, H A 1982. High alcoholism rate in patients with essential tremor. The American journal of psychiatry, 139 11, 1471-3

Singh, M M; Becker, R E; Pitman, R K; Nasrallah, H A; Lal, H; Dufresne, R L; Weber, S S; McCalley-Whitters, M 1982. Diazepam-induced changes in tardive dyskinesia: suggestions for a new conceptual model. Biological psychiatry, 17 6, 729-42

Lyskowski, J; Nasrallah, H A 1981. Slowed release lithium: a review and a comparative study. Journal of clinical psychopharmacology, 1 6, 406-8

Lyskowski, J; Nasrallah, H A 1981. Lithium therapy and the risk for leukemia. The British journal of psychiatry : the journal of mental science, 139 , 256

Nasrallah, H A; Fowler, R C; Judd, L L 1981. Schizophrenia-like illness following head injury. Psychosomatics, 22 4, 359-61

Nasrallah, H A; Jacoby, C G; McCalley-Whitters, M 1981. Cerebellar atrophy in schizophrenia and mania. Lancet, 1 8229, 1102

Nasrallah, H A; Keelor, K; Van Schroeder, C; Whitters, M M 1981. Motoric lateralization in schizophrenic males. The American journal of psychiatry, 138 8, 1114-5

Nasrallah, H A; McChesney, C M 1981. Psychopathology of corpus callosum tumors. Biological psychiatry, 16 7, 663-9

Freed, W J; Nasrallah, H A; Rogol, A D; Wyatt, R J 1980. Propranolol in high doses increases plasma prolactin concentrations in male rats. Biological psychiatry, 15 2, 311-7

Nasrallah, H A 1980. Neuroleptic plasma levels and tardive dyskinesia: a possible link? Schizophrenia bulletin, 6 1, 4-7

Nasrallah, H A; Kleinman, J E; Weinberger, D R; Gillin, J C; Wyatt, R J 1980. Cerebral ventricular enlargement and dopamine synthesis inhibition in chronic schizophrenia. Archives of general psychiatry, 37 12, 1427-

Nasrallah, H A; Kuperman, S; Coryell, W 1980. Reversal of dexamethasone nonsuppression with sleep deprivation in primary depression. The American journal of psychiatry, 137 11, 1463-4

Nasrallah, H A; Pappas, N J; Crowe, R R 1980. Oculogyric dystonia in tardive dyskinesia. The American journal of psychiatry, 137 7, 850-1

Rauscher, F P; Nasrallah, H A; Wyatt, R J 1980. Cutaneous histamine response in schizophrenia. The Journal of clinical psychiatry, 41 2, 44-51

Smith, R E; Low, N N; Nasrallah, H A 1980. Haloperidol and an unrelated sudden death. The American journal of psychiatry, 137 7, 843-4

Kleinman, J E; Potkin, S; Rogol, A; Buchsbaum, M S; Murphy, D L; Gillin, J C; Nasrallah, H A; Wyatt, R J 1979. A correlation between platelet monoamine oxidase activity and plasma prolactin concentrations in man. Science (New York, N.Y.), 206 4417, 479-81

Nasrallah, H A 1979. Tardive dyskinesia symptoms. Psychopharmacology bulletin, 15 4, 5-6

Nasrallah, H A 1979. Vulnerability to disulfiram psychosis. The Western journal of medicine, 130 6, 575-7

Nasrallah, H A 1979. Tardive dyskinesia and depot fluphenazine. The British journal of psychiatry : the journal of mental science, 134 , 550

Nasrallah, H A 1979. Methodological issues in tardive dyskinesia research. Schizophrenia bulletin, 5 1, 1-2

Nasrallah, H A; Holley, T; Janowsky, D S 1979. Opiate antagonism fails to reverse hypnotic-induced analgesia. Lancet, 1 8130, 1355

Nasrallah, H A; Risch, S C; Fowler, R C 1979. Reserpine, serotonin, and schizophrenia. The American journal of psychiatry, 136 6, 856-7

Carman, J S; Wyatt, R J; Nasrallah, H A; O'Brien, P; Gillin, J C 1978. Weight change during various neuropharmacologic manipulations in psychotic inpatients. Acta científica venezolana, 29 3, 178-80

Donnelly, E F; Nasrallah, H A; Wyatt, R J; Gillin, J C; Bigelow, L B 1978. Effects of dopamine synthesis inhibition on WAIS comprehension. Journal of consulting and clinical psychology, 46 3, 385-8

Nasrallah, H A 1978. Factors influencing phenothiazine-induced ECG changes. The American journal of psychiatry, 135 1, 118-9

Nasrallah, H A; Rivera-Calimlin, L; Rogol, A D 1978. Fluphenazine decanoate: plasma concentrations and clinical response [proceedings] Psychopharmacology bulletin, 14 3, 46-7

Potkin, S G; Gillin, J C; Rogol, A; Nasrallah, H A; Wyatt, R J 1978. Baclofen: lack of effect on human plasma prolactin. Communications in psychopharmacology, 2 4, 297-300

Rivera-Calimlim, L; Gift, T; Nasrallah, H A; Wyatt, R J; Lasagna, L 1978. Correlation between plasma concentrations of chlorpromazine and clinical response. Communications in psychopharmacology, 2 3, 215-22

Nasrallah, H A; Donnelly, E F; Bigelow, L B; Rivera-Calimlim, L; Rogol, A; Potkin, S; Rauscher, F P; Wyatt, R J 1977. Inhibition of dopamine synthesis in chronic schizophrenia. Clinical ineffectiveness of metyrosine. Archives of general psychiatry, 34 6, 649-55

Nasrallah, H A; Freed, W J; Rogol, A; Wyatt, R J 1977. Propranolol and prolactin. Lancet, 2 8049, 1175-6

Coffman, J A; Schwarzkopf, S B; Olson, S C; Nasrallah, H A . Midsagittal cerebral anatomy by magnetic resonance imaging. The importance of slice position and thickness. Schizophrenia research, 2 3, 287-94

Gianfrancesco, Frank; Wang, Ruey-Hua; Nasrallah, Henry A . The influence of study design on the results of pharmacoepidemiologic studies of diabetes risk with antipsychotic therapy. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 1, 9-17

Glick, Ira D; Salzman, Carl; Cohen, Bruce M; Klein, Donald F; Moutier, Christine; Nasrallah, Henry A; Ongur, Dost; Wang, Po; Zisook, Sidney . Improving the pedagogy associated with the teaching of psychopharmacology. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry, 31 3, 211-7

Jeste, Dilip V; Nasrallah, Henry A . Schizophrenia and aging: no more dearth of data? The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 11 6, 584-7

Nasrallah, H A . The unintegrated right cerebral hemispheric consciousness as alien intruder: a possible mechanism for Schneiderian delusions in schizophrenia. Comprehensive psychiatry, 26 3, 273-82

Nasrallah, Henry A . Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 1, 57-62

Nasrallah, Henry A; White, Thantween; Nasrallah, Amelia T . Lower mortality in geriatric patients receiving risperidone and olanzapine versus haloperidol: preliminary analysis of retrospective data. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 12 4, 437-9

Petty, F; Nasrallah, H A . Secondary depression in alcoholism: implications for future research. Comprehensive psychiatry, 22 6, 587-95

Ramaswamy, Krishnan; Masand, Prakash S; Nasrallah, Henry A . Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 18 3, 183-94

Rosenberger, P H; Bornstein, R A; Nasrallah, H A; Para, M F; Whitaker, C C; Fass, R J; Rice, R R . Psychopathology in human immunodeficiency virus infection: lifetime and current assessment. Comprehensive psychiatry, 34 3, 150-8